Pyridostigmine induced heart block requiring ICU admission
Myasthenia gravis is an autoimmune disorder that effects an estimated 20 people per 100,000 in the USA per year. Pyridostigmine is a common drug used in the symptomatic treatment of myasthenia gravis. While generally safe and effective, a rare set of patients treated with pyridostigmine encounter ca...
| Published in: | Journal of Community Hospital Internal Medicine Perspectives |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
Greater Baltimore Medical Center
2018-09-01
|
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/20009666.2018.1527668 |